Introduction The burden of Mycobacterium avium complex (MAC) lung disease is increasing globally and treatment outcome is in general poor. Therapeutic drug monitoring has the potential to improve treatment outcome by ensuring adequate drug exposure. However. very limited population-based studies exist for MAC lung disease. https://4thmoontoyers.shop/product-category/pre-order/